TrialPsychopharmacology2021
Interest-activity symptom severity predicts response to ketamine infusion in treatment-resistant depression.
Mu-Hong Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
TrialPsychopharmacology2021
Mu-Hong Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.